STIC Investments — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Pine Tree Therapeutics develops therapies based on targeted protein degradation, with a focus on addressing drug resistance.
BiotechCambridge, US
Ho-Juhn Song(Founder)Ho-Juhn Song, Ph.D(Co-Founder & Chief Executive Officer)
Co-investorsAtinum Investment Co. Ltd.DSC InvestmentKorea Investment PartnersSchmidtSmilegate InvestmentSTIC Ventures
Zeno builds a full-stack battery-as-a-service platform for electric mobility, letting riders power two-, three-, and four-wheel vehicles via a subscription battery that can be charged at home, swapped at stations, or topped up at destination chargers.
CleantechEnergyHardwareMobility & TransportationBozeman, US
Kenneth Micah(Founder)MICHAEL SPENCER(CEO)inMichael Spencer(CEO)Greg Moran(CFO)
Co-investors4DX VenturesAdvantedge FoundersAlumni VenturesCongruent VenturesDG Daiwa VenturesLowercarbon Capital+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




